🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to evaluate the safety and tolerability of abrupt ...
Status
Completed
Location
Administrative Office
Start Date
2007-01
Trial ID
NCT00429260
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy of saredutant 10...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2007-09
Trial ID
NCT00531622
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of sareduta...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2005-04
Trial ID
NCT00250614
Treatments Being Tested
The primary objective is to evaluate the efficacy of a 100 mg dose of sared...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-12
Trial ID
NCT00417118
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of sareduta...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2004-12
Trial ID
NCT00250627
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of sareduta...
Status
Completed
Location
Administrative Office
Start Date
2005-04
Trial ID
NCT00250601
Treatments Being Tested
The purpose of the study is to evaluate the long-term efficacy and safety o...
Status
Completed
Location
Sanofi-Aventis
Start Date
2006-05
Trial ID
NCT00336713
Treatments Being Tested
The purpose of the study is to evaluate the efficacy of saredutant in the t...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-12
Trial ID
NCT00415142
Treatments Being Tested
The primary objective is to evaluate the efficacy of two fixed doses (100 m...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-09
Trial ID
NCT00390533
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of sareduta...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2004-12
Trial ID
NCT00256113
Treatments Being Tested